Industry Insights

Home » Industry Insights
2707, 2017

Consortium Established to Support ICH M7 Compliance

By |July 27th, 2017|Categories: News, Pharmaceutical, Research and Development|Tags: |0 Comments

An industry workgroup comprising toxicologists, pharmaceutical companies and data experts plans to unveil the early results of a data sharing project designed to enhance the safety of drug substances and aid compliance with quality guidelines [...]

2707, 2017

Chemicals Supply Chain Launches New Guidance to Help Companies Meet Waste Packaging Obligations

By |July 27th, 2017|Categories: Manufacturing and Production, News, Pharmaceutical|Tags: |0 Comments

This guidance document, “The assessment and classification of waste packaging” was developed by trade associations representing companies operating in the chemicals supply chain that use packaging. The Environment Agency, Natural Resources Wales and Scottish Environment Protection [...]

2707, 2017

Lonza Pharma&Biotech Launches Ibex Solutions – An Innovative New Concept in Biological Manufacturing and Development

By |July 27th, 2017|Categories: Manufacturing and Production, News, Pharmaceutical|Tags: |0 Comments

Lonza’s commitment to constant innovation and adding value to its customers and partners is today demonstrated by the launch of Ibex Solutions – a unique addition to its current offering. Ibex Solutions is an innovative [...]

2707, 2017

PatSnap Launches Cloud Platform to Accelerate Drug Research

By |July 27th, 2017|Categories: Drug Discovery & Development, News, Pharmaceutical|Tags: , |0 Comments

PatSnap, the global intellectual property analytics company backed by Sequoia and used by innovative companies to accelerate their research and development (R&D), has announced the launch of Chemical by PatSnap, a Software as-a-Service (SaaS) platform [...]

2607, 2017

New Generation Asthma Drug Gets Approval for NHS Use

By |July 26th, 2017|Categories: News, Pharmaceutical, Research and Development|Tags: |0 Comments

Asthma UK welcomes the recommendation to provide a new severe asthma treatment on the NHS and urges its speedy adoption. The National Institute for Health and Care Excellence (NICE) recently announced its recommendation, a decision [...]

2607, 2017

Global Clostridium difficile Infections Market to Approach $1.7 Billion by 2026

By |July 26th, 2017|Categories: Market insights, News, Pharmaceutical|Tags: |0 Comments

The Clostridium difficile infections (CDIs) space across the seven major markets of the US, France, Germany, Italy, Spain, the UK and Japan is set to grow from just under $630 million in 2016 to almost [...]